The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Umbilical Cord Blood (UCB) Stem Cell Market Research Report 2025
Synopsis
Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells.
The global Umbilical Cord Blood (UCB) Stem Cell market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Umbilical Cord Blood (UCB) Stem Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Umbilical Cord Blood (UCB) Stem Cell.
Report Scope
The Umbilical Cord Blood (UCB) Stem Cell market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Umbilical Cord Blood (UCB) Stem Cell market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Umbilical Cord Blood (UCB) Stem Cell companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advanced Cell Technology
Athersys
California Stem Cell
Cytori Therapeutics
Mesoblast
Opexa Therapeutics
Caladrius Biosciences
Segment by Type
Stem Cell Transplant
Autologous Transplant
Allogenic Transplant
Transplant Medicine
Regenerative Medicine
Others
Segment by Application
Therapeutics Service Companies
Private And Government Research Institutes
Academic Institutes
Research Based Pharmaceutical Companies
Public And Private Cord Blood Banks
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Umbilical Cord Blood (UCB) Stem Cell companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells.
The global Umbilical Cord Blood (UCB) Stem Cell market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Umbilical Cord Blood (UCB) Stem Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Umbilical Cord Blood (UCB) Stem Cell.
Report Scope
The Umbilical Cord Blood (UCB) Stem Cell market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Umbilical Cord Blood (UCB) Stem Cell market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Umbilical Cord Blood (UCB) Stem Cell companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advanced Cell Technology
Athersys
California Stem Cell
Cytori Therapeutics
Mesoblast
Opexa Therapeutics
Caladrius Biosciences
Segment by Type
Stem Cell Transplant
Autologous Transplant
Allogenic Transplant
Transplant Medicine
Regenerative Medicine
Others
Segment by Application
Therapeutics Service Companies
Private And Government Research Institutes
Academic Institutes
Research Based Pharmaceutical Companies
Public And Private Cord Blood Banks
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Umbilical Cord Blood (UCB) Stem Cell companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Umbilical Cord Blood (UCB) Stem Cell Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cell Transplant
1.2.3 Autologous Transplant
1.2.4 Allogenic Transplant
1.2.5 Transplant Medicine
1.2.6 Regenerative Medicine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Umbilical Cord Blood (UCB) Stem Cell Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Therapeutics Service Companies
1.3.3 Private And Government Research Institutes
1.3.4 Academic Institutes
1.3.5 Research Based Pharmaceutical Companies
1.3.6 Public And Private Cord Blood Banks
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Umbilical Cord Blood (UCB) Stem Cell Market Perspective (2019-2030)
2.2 Umbilical Cord Blood (UCB) Stem Cell Growth Trends by Region
2.2.1 Global Umbilical Cord Blood (UCB) Stem Cell Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Umbilical Cord Blood (UCB) Stem Cell Historic Market Size by Region (2019-2024)
2.2.3 Umbilical Cord Blood (UCB) Stem Cell Forecasted Market Size by Region (2025-2030)
2.3 Umbilical Cord Blood (UCB) Stem Cell Market Dynamics
2.3.1 Umbilical Cord Blood (UCB) Stem Cell Industry Trends
2.3.2 Umbilical Cord Blood (UCB) Stem Cell Market Drivers
2.3.3 Umbilical Cord Blood (UCB) Stem Cell Market Challenges
2.3.4 Umbilical Cord Blood (UCB) Stem Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Umbilical Cord Blood (UCB) Stem Cell Players by Revenue
3.1.1 Global Top Umbilical Cord Blood (UCB) Stem Cell Players by Revenue (2019-2024)
3.1.2 Global Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share by Players (2019-2024)
3.2 Global Umbilical Cord Blood (UCB) Stem Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Umbilical Cord Blood (UCB) Stem Cell Revenue
3.4 Global Umbilical Cord Blood (UCB) Stem Cell Market Concentration Ratio
3.4.1 Global Umbilical Cord Blood (UCB) Stem Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Umbilical Cord Blood (UCB) Stem Cell Revenue in 2023
3.5 Umbilical Cord Blood (UCB) Stem Cell Key Players Head office and Area Served
3.6 Key Players Umbilical Cord Blood (UCB) Stem Cell Product Solution and Service
3.7 Date of Enter into Umbilical Cord Blood (UCB) Stem Cell Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Umbilical Cord Blood (UCB) Stem Cell Breakdown Data by Type
4.1 Global Umbilical Cord Blood (UCB) Stem Cell Historic Market Size by Type (2019-2024)
4.2 Global Umbilical Cord Blood (UCB) Stem Cell Forecasted Market Size by Type (2025-2030)
5 Umbilical Cord Blood (UCB) Stem Cell Breakdown Data by Application
5.1 Global Umbilical Cord Blood (UCB) Stem Cell Historic Market Size by Application (2019-2024)
5.2 Global Umbilical Cord Blood (UCB) Stem Cell Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Umbilical Cord Blood (UCB) Stem Cell Market Size (2019-2030)
6.2 North America Umbilical Cord Blood (UCB) Stem Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Umbilical Cord Blood (UCB) Stem Cell Market Size by Country (2019-2024)
6.4 North America Umbilical Cord Blood (UCB) Stem Cell Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Umbilical Cord Blood (UCB) Stem Cell Market Size (2019-2030)
7.2 Europe Umbilical Cord Blood (UCB) Stem Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Umbilical Cord Blood (UCB) Stem Cell Market Size by Country (2019-2024)
7.4 Europe Umbilical Cord Blood (UCB) Stem Cell Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Umbilical Cord Blood (UCB) Stem Cell Market Size (2019-2030)
8.2 Asia-Pacific Umbilical Cord Blood (UCB) Stem Cell Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Umbilical Cord Blood (UCB) Stem Cell Market Size by Region (2019-2024)
8.4 Asia-Pacific Umbilical Cord Blood (UCB) Stem Cell Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Umbilical Cord Blood (UCB) Stem Cell Market Size (2019-2030)
9.2 Latin America Umbilical Cord Blood (UCB) Stem Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Umbilical Cord Blood (UCB) Stem Cell Market Size by Country (2019-2024)
9.4 Latin America Umbilical Cord Blood (UCB) Stem Cell Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Umbilical Cord Blood (UCB) Stem Cell Market Size (2019-2030)
10.2 Middle East & Africa Umbilical Cord Blood (UCB) Stem Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Umbilical Cord Blood (UCB) Stem Cell Market Size by Country (2019-2024)
10.4 Middle East & Africa Umbilical Cord Blood (UCB) Stem Cell Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advanced Cell Technology
11.1.1 Advanced Cell Technology Company Detail
11.1.2 Advanced Cell Technology Business Overview
11.1.3 Advanced Cell Technology Umbilical Cord Blood (UCB) Stem Cell Introduction
11.1.4 Advanced Cell Technology Revenue in Umbilical Cord Blood (UCB) Stem Cell Business (2019-2024)
11.1.5 Advanced Cell Technology Recent Development
11.2 Athersys
11.2.1 Athersys Company Detail
11.2.2 Athersys Business Overview
11.2.3 Athersys Umbilical Cord Blood (UCB) Stem Cell Introduction
11.2.4 Athersys Revenue in Umbilical Cord Blood (UCB) Stem Cell Business (2019-2024)
11.2.5 Athersys Recent Development
11.3 California Stem Cell
11.3.1 California Stem Cell Company Detail
11.3.2 California Stem Cell Business Overview
11.3.3 California Stem Cell Umbilical Cord Blood (UCB) Stem Cell Introduction
11.3.4 California Stem Cell Revenue in Umbilical Cord Blood (UCB) Stem Cell Business (2019-2024)
11.3.5 California Stem Cell Recent Development
11.4 Cytori Therapeutics
11.4.1 Cytori Therapeutics Company Detail
11.4.2 Cytori Therapeutics Business Overview
11.4.3 Cytori Therapeutics Umbilical Cord Blood (UCB) Stem Cell Introduction
11.4.4 Cytori Therapeutics Revenue in Umbilical Cord Blood (UCB) Stem Cell Business (2019-2024)
11.4.5 Cytori Therapeutics Recent Development
11.5 Mesoblast
11.5.1 Mesoblast Company Detail
11.5.2 Mesoblast Business Overview
11.5.3 Mesoblast Umbilical Cord Blood (UCB) Stem Cell Introduction
11.5.4 Mesoblast Revenue in Umbilical Cord Blood (UCB) Stem Cell Business (2019-2024)
11.5.5 Mesoblast Recent Development
11.6 Opexa Therapeutics
11.6.1 Opexa Therapeutics Company Detail
11.6.2 Opexa Therapeutics Business Overview
11.6.3 Opexa Therapeutics Umbilical Cord Blood (UCB) Stem Cell Introduction
11.6.4 Opexa Therapeutics Revenue in Umbilical Cord Blood (UCB) Stem Cell Business (2019-2024)
11.6.5 Opexa Therapeutics Recent Development
11.7 Caladrius Biosciences
11.7.1 Caladrius Biosciences Company Detail
11.7.2 Caladrius Biosciences Business Overview
11.7.3 Caladrius Biosciences Umbilical Cord Blood (UCB) Stem Cell Introduction
11.7.4 Caladrius Biosciences Revenue in Umbilical Cord Blood (UCB) Stem Cell Business (2019-2024)
11.7.5 Caladrius Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
